What does this article add?
In the largest prospective AF dataset from the Balkans, more than one third of patients received a rhythm control strategy, and these patients tended to be younger with less comorbidities than those managed with rate control. EHRA symptom score is not significantly associated with rhythm control. The most commonly used antiarrhythmic agents were amiodarone, followed by propafenone.